Hakutulokset - C. Chouaïd

Tarkenna hakua
  1. 1
    Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review

    Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review Tekijä Kokuvi Atsou, C. Chouaïd, Gilles Hejblum

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date

    ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date Tekijä S. Gendarme, Olivier Bylicki, C. Chouaïd, Florian Guisier

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Papillon trial, a major advance in the management of patients with metastatic, mutated-EGFR exon 20 insertion non-small-cell lung cancer

    Papillon trial, a major advance in the management of patients with metastatic, mutated-EGFR exon 20 insertion non-small-cell lung cancer Tekijä C. Chouaïd, Jean‐Baptiste Assié, J.B. Auliac

    Julkaistu 2025
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Delays for diagnosis and treatment of lung cancers: a systematic review

    Delays for diagnosis and treatment of lung cancers: a systematic review Tekijä F. Viñas, I. Ben Hassen, L. Jabot, I. Monnet, C. Chouaïd

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care

    Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care Tekijä Olivier Bylicki, Morgane Didier, F. Rivière, J. Margery, F. Grassin, C. Chouaïd

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study

    Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study Tekijä Laurent Laforest, Nicolás Roche, Gilles Devouassoux, Manon Belhassen, C. Chouaïd, M. Ginoux, Éric Van Ganse

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Lung cancer and interstitial lung disease: a literature review

    Lung cancer and interstitial lung disease: a literature review Tekijä Jean‐Marc Naccache, Q. Gibiot, I. Monnet, Martine Antoine, Marie Wislez, C. Chouaïd, Jacques Cadranel

    Julkaistu 2018
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France

    Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-smal... Tekijä C. Chouaïd, L. Bensimon, E. Clay, A. Millier, L. Lévy-Bachelot, Min Huang, Pierre Lévy

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection

    Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection Tekijä Joël Gozlan, J.‐M. Salord, C. Chouaïd, Claudine Duvivier, O Picard, Marie‐Caroline Meyohas, Jean‐Claude Petit

    Julkaistu 1993
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Chronic bronchitis in the general population: Influence of age, gender and socio-economic conditions

    Chronic bronchitis in the general population: Influence of age, gender and socio-economic conditions Tekijä Alexis Ferré, C. Fuhrman, Mahmoud Zureik, C. Chouaïd, A. Vergnenègre, Gérard Huchon, Marie-Christine Delmas, Nicolás Roche

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials

    Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials Tekijä Thierry Landre, G. Justeau, Jean‐Baptiste Assié, Kader Chouahnia, Claire Davoine, Chérifa Taleb, C. Chouaïd, Boris Duchemann

    Julkaistu 2021
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment

    Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment Tekijä H. Picchi, Christine Mateus, C. Chouaïd, Benjamin Besse, Aurélien Marabelle, Jean‐Marie Michot, Stéphane Champiat, Anne-Laure Voisin, Olivier Lambotte

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Editorial
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    The association between asthma control, health care costs, and quality of life in France and Spain

    The association between asthma control, health care costs, and quality of life in France and Spain Tekijä Marianne Doz, C. Chouaïd, Laure Com-Ruelle, Eduardo Calvo, Max Brosa, J. Robert, L. Decuypère, C. Pribil, Alicia Huerta, B. Detournay

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis

    Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis Tekijä Thierry Landre, Abdoulaye Karaboué, Zachary S. Buchwald, Pasquale F. Innominato, David C. Qian, Jean‐Baptiste Assié, C. Chouaïd, Françis Lévi, Boris Duchemann

    Julkaistu 2024
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Preclinical and Preliminary Clinical Activity of NVP-BKM120, an Oral Pan-Class I PI3K Inhibitor, in the Brain

    Preclinical and Preliminary Clinical Activity of NVP-BKM120, an Oral Pan-Class I PI3K Inhibitor, in the Brain Tekijä Michel Maira, Christian Schnell, Pier‐Luigi Lollini, C. Chouaïd, Peter Schmid, Paolo Nanni, Dawn Lam, Emmanuelle di Tomaso, Cristian Massacesi, Jordi Rodón

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601)

    Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601) Tekijä C. Decroisette, I. Monnet, H. Bérard, Gilles Quéré, H. Le Caer, Suzanna Bota, Clarisse Audigier-Valette, L. Gérinière, Jean-Marc Vernejoux, C. Chouaïd

    Julkaistu 2011
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study

    Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study Tekijä J. Le Treut, M. C. Sault, H. Léna, P.-J. Souquet, A. Vergnenègre, H. Le Caer, H. Bérard, S. Boffa, I. Monnet, Diane Damotte, C. Chouaïd

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC

    Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC Tekijä Paul Lesueur, Alexandre Escande, Juliette Thariat, E. Vauléon, I. Monnet, Alexis B. Cortot, D. Lerouge, S. Danhier, Pascal Dô, Catherine Dubos‐Arvis, C. Chouaïd, Radj Gervais

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy

    Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy Tekijä Romain-David Seban, Jean‐Baptiste Assié, Etienne Giroux‐Leprieur, Marie-Ange Massiani, G. Bonardel, C. Chouaïd, Nicolas Deleval, Capucine Richard, Laura Mezquita, Nicolas Girard, Laurence Champion

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis

    Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis Tekijä Matteo Giaj Levra, François-Emery Cotté, R. Corre, C. Calvet, Anne-Françoise Gaudin, John R. Penrod, V. Grumberg, B. Jouaneton, R. Jolivel, Jean‐Baptiste Assié, C. Chouaïd

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: